However, one study indicates that regular use of aspirin after diagnosis only has beneficial effects among patients with mutated-PIK3CA (phosphatidylinositol-4, 5-bisphosphonate 3-kinase, catalytic subunit alpha) colorectal cancer, but not among patients with wild-type PIK3CA cancer [6]. This evidence concerns the gene PIK3CA and cancer.